TickerFacts.

A business in context

KNSA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001857177-26-000008

  2. 4 · Ownership change

    Report date 2026-09-01 · 0001835458-26-000012

  3. 4 · Ownership change

    Report date 2026-09-01 · 0001741533-26-000010

  4. 4 · Ownership change

    Report date 2026-09-01 · 0001532218-26-000016

  5. 4 · Ownership change

    Report date 2026-09-01 · 0001532218-26-000014

  6. 4 · Ownership change

    Report date 2026-07-15 · 0001464583-26-000008

  7. 4 · Ownership change

    Report date 2026-08-19 · 0001384243-26-000014

  8. 4 · Ownership change

    Report date 2026-08-01 · 0001454983-26-000008

  9. 8-K · Current report

    Report date 2026-07-28 · 0001730430-26-000031 · Items 2.02,9.01

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-087545

  11. 8-K · Current report

    Report date 2026-05-29 · 0001730430-26-000029 · Items 5.07

  12. 8-K · Current report

    Report date 2026-05-21 · 0001730430-26-000025 · Items 1.01,9.01

  13. 8-K · Current report

    Report date 2026-04-30 · 0001730430-26-000021 · Items 5.02

  14. 8-K · Current report

    Report date 2026-04-28 · 0001730430-26-000017 · Items 2.02,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-050359

  16. DEF 14A · Proxy statement

    Report date 2026-05-19 · 0001104659-26-044410

  17. 8-K · Current report

    Report date 2026-02-24 · 0001730430-26-000014 · Items 2.02,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-019168

  19. 8-K · Current report

    Report date 2026-01-10 · 0001730430-26-000010 · Items 5.02

  20. 8-K · Current report

    Report date 2026-01-12 · 0001730430-26-000005 · Items 2.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-103180

  22. 8-K · Current report

    Report date 2025-10-28 · 0001104659-25-102834 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-09-03 · 0001104659-25-086689 · Items 7.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-009738

  25. 8-K · Current report

    Report date 2025-07-29 · 0001104659-25-071413 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-06-05 · 0001104659-25-056665 · Items 7.01,9.01

  27. 8-K · Current report

    Report date 2025-06-03 · 0001104659-25-055990 · Items 5.07

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-005847

  29. 8-K · Current report

    Report date 2025-04-29 · 0001104659-25-040641 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-04-17 · 0001104659-25-038041 · Items 5.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-06-03 · 0001104659-25-036852

  32. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-001505

  33. 8-K · Current report

    Report date 2025-02-21 · 0001104659-25-016725 · Items 1.02,2.02,2.05,9.01

  34. 8-K · Current report

    Report date 2025-01-13 · 0001104659-25-002858 · Items 2.02,9.01

  35. SC 13G/A · Ownership disclosure

    0001104659-24-118928

  36. SC 13G/A · Ownership disclosure

    0000902664-24-006617

  37. SC 13G/A · Ownership disclosure

    0001104659-24-117745

  38. SC 13G · Ownership disclosure

    0002012383-24-004025

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001558370-24-013840

  40. 8-K · Current report

    Report date 2024-10-29 · 0001104659-24-112034 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 15 transaction rows15SGrant / award: 37 transaction rows37AExercise / conversion: 66 transaction rows66MTax / exercise payment: 12 transaction rows12FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

132 matching transaction rows. Showing 1–50.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-01
2026-06-02
Patel Sanj KC · Conversion
Acquired
Class A Ordinary Share900000.0—
2026-06-01
2026-06-02
Patel Sanj KC · Conversion
Disposed
Class B Ordinary Shares
Derivative security
900000.00.0
2026-05-29
2026-06-02
McCain Tracey LM · Exercise / conversion
Acquired
Class A Ordinary Share2799.0—
2026-05-29
2026-06-02
McCain Tracey LA · Grant / award
Acquired
Restricted Share Units
Derivative security
2026.00.0
2026-05-29
2026-06-02
McCain Tracey LM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2799.00.0
2026-05-29
2026-06-02
McCain Tracey LA · Grant / award
Acquired
Share Option
Derivative security
12158.00.0
2026-05-29
2026-06-02
Levy Richard SM · Exercise / conversion
Acquired
Class A Ordinary Share2799.0—
2026-05-29
2026-06-02
Levy Richard SA · Grant / award
Acquired
Share Option
Derivative security
12158.00.0
2026-05-29
2026-06-02
Levy Richard SA · Grant / award
Acquired
Restricted Share Units
Derivative security
2026.00.0
2026-05-29
2026-06-02
Levy Richard SM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2799.00.0
2026-05-29
2026-06-02
Malley ThomasM · Exercise / conversion
Acquired
Class A Ordinary Shares2799.0—
2026-05-29
2026-06-02
Malley ThomasA · Grant / award
Acquired
Share Option
Derivative security
12158.00.0
2026-05-29
2026-06-02
Malley ThomasM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2799.00.0
2026-05-29
2026-06-02
Malley ThomasA · Grant / award
Acquired
Restricted Share Units
Derivative security
2026.00.0
2026-05-29
2026-06-02
Quart Barry DM · Exercise / conversion
Acquired
Class A Ordinary Share2799.0—
2026-05-29
2026-06-02
Quart Barry DA · Grant / award
Acquired
Share Option
Derivative security
12158.00.0
2026-05-29
2026-06-02
Quart Barry DM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2799.00.0
2026-05-29
2026-06-02
Quart Barry DA · Grant / award
Acquired
Restricted Share Units
Derivative security
2026.00.0
2026-05-29
2026-06-02
Cole G BradleyM · Exercise / conversion
Acquired
Class A Ordinary Share2799.0—
2026-05-29
2026-06-02
Cole G BradleyM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2799.00.0
2026-05-29
2026-06-02
Cole G BradleyA · Grant / award
Acquired
Restricted Share Units
Derivative security
2026.00.0
2026-05-29
2026-06-02
Cole G BradleyA · Grant / award
Acquired
Share Option
Derivative security
12158.00.0
2026-05-29
2026-06-02
Popovits Kimberly JM · Exercise / conversion
Acquired
Class A Ordinary Share2799.0—
2026-05-29
2026-06-02
Popovits Kimberly JA · Grant / award
Acquired
Restricted Share Units
Derivative security
2026.00.0
2026-05-29
2026-06-02
Popovits Kimberly JM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2799.00.0
2026-05-29
2026-06-02
Popovits Kimberly JA · Grant / award
Acquired
Share Option
Derivative security
12158.00.0
2026-05-29
2026-06-02
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Class A Ordinary Shares6078.00.0
2026-05-29
2026-06-02
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Class A Ordinary Shares6078.00.0
2026-05-29
2026-06-02
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Non- Qualified Share Option (right to buy)
Derivative security
36474.00.0
2026-05-29
2026-06-02
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Non- Qualified Share Option (right to buy)
Derivative security
36474.00.0
2026-05-01
2026-05-05
Paolini John F.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share37327.053.52
2026-05-01
2026-05-05
Paolini John F.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share21097.054.04
2026-05-01
2026-05-05
Paolini John F.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Ordinary Share58424.010.36
2026-05-01
2026-05-05
Paolini John F.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option
Derivative security
58424.00.0
2026-05-01
2026-05-01
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Ordinary Share48565.030.93
2026-05-01
2026-05-01
Patel Sanj K
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share48565.054.02
2026-05-01
2026-05-01
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option
Derivative security
48565.00.0
2026-04-30
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share2141.054.01
2026-04-30
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Ordinary Share2141.030.93
2026-04-30
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option
Derivative security
2141.00.0
2026-04-29
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share22544.054.01
2026-04-29
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Ordinary Share22544.030.93
2026-04-29
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option
Derivative security
22544.00.0
2026-04-28
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share51750.054.02
2026-04-28
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share243596.052.02
2026-04-28
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share113673.051.47
2026-04-28
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
S · Sale
Disposed
Class A Ordinary Share74635.050.43
2026-04-28
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Ordinary Share51750.030.93
2026-04-28
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Ordinary Share431904.010.36
2026-04-28
2026-04-30
Patel Sanj K
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Share Option
Derivative security
51750.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001730430Kiniksa Pharmaceuticals International, plc

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Kiniksa Pharmaceuticals, Ltd. · former SEC name · 2018-02-27 to 2024-06-28

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$423.24M$450.52M
2023-12-31$270.26M$296.15M
2022-12-31$220.18M$251.18M
2021-12-31$38.54M$47.49M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗